Originally posted by pmiguel
View Post
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
-
Originally posted by ECO View PostJust saw this...
With regard to your two examples of "basic" issues...I'm not sure why you expect dsDNA and RNA to run at the same mobility on an RNA chip...and then expect Agilent to support it?
Actually, I now know roughly know what their relative rates are, so I just want Agilent to provide that information to all their customers. That is the level of support I expect.
Originally posted by ECO View PostDid you denature the dsDNA?
Originally posted by ECO View PostDo you know the dye-binding affinity for ssDNA versus dsDNA versus RNA?
Originally posted by ECO View PostThere is almost certainly a different ratio of dye:nucleic acid for RNA vs DNA which could totally explain the mobility difference, let alone how the software works to normalize even the mobility times shown.
By the way, dye:nucleic acid ratio differences between ss and ds are a reasonable hypothesis about the unexpected relative migration speeds. But why are we hypothesizing about something Agilent will almost certainly know for sure?
Originally posted by ECO View PostThe size calculations for your sample are based on the mobility of the ladder, and normalized to the marker peaks included in each lane. It's essential that all those molecules are of the same general mobility in the gel matrix. It's an exercise in futility to try to size dsDNA against an RNA ladder, and the converse, as the ladder and the marker peaks will migrate differently from your sample.
Originally posted by ECO View PostThere is a lot more going on from a biochemical standpoint than you appear to be giving Agilent credit for. Measure DNA on a DNA chip with a DNA dye against a DNA ladder with DNA lane markers. Measure RNA on an RNA chip with an RNA specific dye against an RNA ladder with RNA lane markers. OR include your own standards, make your own measurements for standards, and calculate your own molecular sizes. Neither of the observations you've made in your two threads are surprising in the slightest.
Originally posted by ECO View PostTo address the original poster's question, I still feel that when you take all the parameters into account (time, data quality, reproducibility, instrument cost, etc), the bioanalyzer performs very valuable functions for an NGS lab. If you have a dialed in protocol for one sample type/size, you definitely can get away without it. If you ever expect to troubleshoot library prep, shearing, or similar, it's great.
Do you really need it? I don't think so. But I will admit that this is easy for me to say because we have one and use it frequently -- daily, on average.
Also, to be fair to Agilent they have already contacted me with regards to the post above and asked for clarification about complaints I had. So it isn't like they don't put any effort into dealing with customer complaints. I replied with my laundry list of stuff I thought they could do better with and offered to specify that we have a bioanalyzer and use it heavily, etc if they thought I was being unfair.
--
Phillip
Leave a comment:
-
With regard to your two examples of "basic" issues...I'm not sure why you expect dsDNA and RNA to run at the same mobility on an RNA chip...and then expect Agilent to support it? Did you denature the dsDNA? Do you know the dye-binding affinity for ssDNA versus dsDNA versus RNA? There is almost certainly a different ratio of dye:nucleic acid for RNA vs DNA which could totally explain the mobility difference, let alone how the software works to normalize even the mobility times shown.
The size calculations for your sample are based on the mobility of the ladder, and normalized to the marker peaks included in each lane. It's essential that all those molecules are of the same general mobility in the gel matrix. It's an exercise in futility to try to size dsDNA against an RNA ladder, and the converse, as the ladder and the marker peaks will migrate differently from your sample.
There is a lot more going on from a biochemical standpoint than you appear to be giving Agilent credit for. Measure DNA on a DNA chip with a DNA dye against a DNA ladder with DNA lane markers. Measure RNA on an RNA chip with an RNA specific dye against an RNA ladder with RNA lane markers. OR include your own standards, make your own measurements for standards, and calculate your own molecular sizes. Neither of the observations you've made in your two threads are surprising in the slightest.
To address the original poster's question, I still feel that when you take all the parameters into account (time, data quality, reproducibility, instrument cost, etc), the bioanalyzer performs very valuable functions for an NGS lab. If you have a dialed in protocol for one sample type/size, you definitely can get away without it. If you ever expect to troubleshoot library prep, shearing, or similar, it's great.
Leave a comment:
-
We are also considering the IonTorrent but what about the DNA fragmentation?
So there is no way in hell we are buying a Covaris(its too expensive!), we've been using Nextera for this. Does anybody know where I can find a comparison between Covaris, Nextera and the new IonShear kits??
Leave a comment:
-
Thanks for the info. I know having the bioanalyzer is desirable, but sadly our budget for equipment was cut down, so, we'll have to manage without it and learn the hard way.
Leave a comment:
-
One huge advantage of the Bioanalyzer over gel electrophoresis is sensitivity, which allows you to visualize the size distribution and degree of adapter dimer contamination of your final libraries even at dilute (< 1ng/ul) concentrations. I agree with the points that Phillip raised; the instrument is finicky and tech support is lousy.
-Harold
Leave a comment:
-
I disagree with Eric. We use our Bioanalyzer heavily. But I am far from certain it is a necessity. In fact, it is a rather cantankerous instrument--easily 10% of lanes have bizarre spikes and bulges that disappear when repeated. The reagents are expensive and in some cases go bad even before their expiration date. Their tech support is incapable or unwilling to detail basic, non-intuitive, issues with the function of the instrument. (For example this and this.) Most of what it does can be emulated with minigels and decent gel documentation software.
To be fair, like I said above, we use ours heavily. But if I were starting again I would seriously consider a Caliper instrument instead. And if I were starting a PGM core -- or any other core where $20K was a sizable percentage of the cost of my start up, I would strongly consider doing without.
--
Phillip
- Likes 1
Leave a comment:
-
In my experience, especially during the early stages of getting an NGS system up in new hands, the bioanalyzer is an indispensable piece of QC equipment.
You'll find it valuable to check libraries post shearing, post ligation, post size selection, post PCR, etc. You could do all these on gels, except perhaps quantitate accurately. Once you get the protocols dialed in for your applications, you may find it less necessary.
Leave a comment:
-
Bioanalyzer indispensable?
Hi, at my lab we are going to buy a PGM, plus almost all the recommended equipment, one-touch, qubit, server, pippin and minifuge. As we run out of money, no bioanalyzer or sonicator. The question(s) is, is the bioanalyzer really essential? Are we going to waste our money on a very expensive door stop? Can we get away by using other methods that do not require the bioanalyzer?
Thanks for any advise on this question from a novice.
Latest Articles
Collapse
-
by seqadmin
Metagenomics has improved the way researchers study microorganisms across diverse environments. Historically, studying microorganisms relied on culturing them in the lab, a method that limits the investigation of many species since most are unculturable1. Metagenomics overcomes these issues by allowing the study of microorganisms regardless of their ability to be cultured or the environments they inhabit. Over time, the field has evolved, especially with the advent...-
Channel: Articles
09-23-2024, 06:35 AM -
-
by seqadmin
During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.
Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...-
Channel: Articles
09-09-2024, 10:59 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 10-02-2024, 04:51 AM
|
0 responses
8 views
0 likes
|
Last Post
by seqadmin
10-02-2024, 04:51 AM
|
||
Started by seqadmin, 10-01-2024, 07:10 AM
|
0 responses
14 views
0 likes
|
Last Post
by seqadmin
10-01-2024, 07:10 AM
|
||
Started by seqadmin, 09-30-2024, 08:33 AM
|
0 responses
18 views
0 likes
|
Last Post
by seqadmin
09-30-2024, 08:33 AM
|
||
Started by seqadmin, 09-26-2024, 12:57 PM
|
0 responses
16 views
0 likes
|
Last Post
by seqadmin
09-26-2024, 12:57 PM
|
Leave a comment: